中国癌症杂志 ›› 2014, Vol. 24 ›› Issue (4): 292-298.doi: 10.3969/j.issn.1007-3969.2014.04.009

• 论著 • 上一篇    下一篇

小干扰RNA阻断周期蛋白依赖激酶4对子宫内膜癌细胞生物学行为的影响

常军1,刘玲芳1,郑殊娟1,张婵2   

  1. 1. 四川省妇幼保健院妇科,四川 成都 610045 ;
    2. 重庆市第三人民医院妇产科,重庆 400014
  • 出版日期:2014-04-30 发布日期:2014-05-06
  • 通信作者: 常军 E-mail:changjun505@126.com

Effects of a small interfering RNA targeting CDK4 gene on the biological functions of endometrial cancer cells

CHANG Jun1, LIU Fang-ling1, ZHENG Shu-juan1, ZHANG Chan2   

  1. 1.Department of Gynecology, the Sichuan Maternity and Child Health Hospital, Chengdu Sichuang 610045, China; 2.Department of Gynecology and Obstetrics, the Third People’s hospital of Chongqing Municipality, Chongqing 400014, China
  • Published:2014-04-30 Online:2014-05-06
  • Contact: CHANG Jun E-mail: changjun505@126.com

摘要:

背景与目的:细胞周期蛋白依赖激酶4(cyclin-dependent kinase 4CDK4)是调控细胞周期进程的重要激酶之一,有实验报道其在子宫内膜癌中呈高表达,但是其在子宫内膜癌细胞中的生物学功能及其可能机制还不十分明确。本研究旨在通过小干扰RNA(small interfering RNAsiRNA)沉默CDK4表达,并检测其对人子宫内膜癌HEC-1B细胞生物学行为的影响及其可能机制方法:将化学合成的CDK4-siRNA转染至HEC-1B细胞;实时荧光定量PCR法检测转染前后细胞中CDK4mRNA表达量变化;Western blot检测转染前后细胞CDK4、视母细胞瘤基因(retinoblastoma geneRb)及其下游p-Rb的蛋白表达量的变化;分别采用CCK-8法、流式细胞仪、Transwell肿瘤细胞侵袭实验检测细胞增殖、周期、凋亡以及侵袭能力的变化结果:转染后HEC-1B细胞中CDK4 mRNA及蛋白表达均明显下降(P<0.01);抑制CDK4表达后,抑制HEC-1B细胞的增殖及侵袭,转染si-CDK4组细胞发生侵袭数为(117±21)个,而转染si-control组及未处理组分别为(269±39)个和(262±35)个,差异具有统计学意义(P<0.01);细胞转染后早期凋亡率为(21.7±3.5)%,较未处理组[(12.4±2.1)%]和si-control组[(11.8±1.9)%]明显增加(P<0.01);细胞周期分布发生变化,G1期比例增加(P<0.01)S期细胞比例降低(P<0.01);进一步的Western blot结果显示,抑制CDK4表达后,细胞内p-Rb表达下降,但是总Rb表达无明显变化结论:针对CDK4基因的特异性小RNA干扰片段能够下调CDK4基因在子宫内膜癌细胞中的表达,抑制肿瘤生物学进程

关键词: 子宫内膜癌, RNA干扰, 细胞周期蛋白依赖激酶4, 视母细胞瘤基因

Abstract:

Background and purpose: Cyclin-dependent kinase 4 (CDK4) is a kind of protein kinases regulating the cell cycle progression, which has been reported to be overexpressed in endometrial carcinoma tissues. But the role of CDK4 in endometrial carcinogenesis and relative mechanisms has not been identified yet. In this study, we used a small interfering RNA targeting CDK4, and explored the effects of CDK4 on endometrial cancer cells HEC-1B biological function and relative mechanisms. Methods: The chemically synthesized small interfering RNA targeting CDK4 (si-CDK4) was transiently transfected into HEC-1B cells; the quantitative real time-PCR assays and Western blot assays were performed to explore the mRNA and protein expression levels of CDK4 and its downstream genes, Rb and p-Rb, in HEC-1B cells upon transfection; Moreover, the CCK-8, flow cytometry (FCM) and invasion assays were performed to indentify the effects of si-CDK4 on the proliferation, cell cycle distribution, apoptosis and invasion abilities of HEC-1B cells, respectively. Results: The results showed that the mRNA and protein expressions of CDK4 were suppressed in HEC-1B cells upon transfection with si-CDK4 (P<0.01); Suppression of CDK4 inhibited cell proliferation and invasion of HEC-1B cells; the number of cells migrating through the transwell membrane in si- CDK4 group was 117±21, which was much fewer than the cells in si-control (269±39) and untreated groups (262±35) (P<0.01); the early apoptosis rate of cells treated with si-CDK4 (21.7±3.5)%was much higher than the untreated (12.4±2.1)%and si-control groups (11.8±1.9)%(P<0.01); moreover, suppression of CDK4 increased cells in G1 phase (P<0.01) and correspondingly decreased cells in S phase (P<0.01); further Western blot results showed that suppression of CDK4 down-regulated the expression of p-Rb in cells, but did not influence the expression of total Rb. Conclusion: CDK4-siRNA specifically and efficiently blocks the constitutively activated CDK4 in human endometrial cancer cells HEC-1B, resulting in tumor suppression.

Key words: Endometrial carcinoma, RNA interference, Cyclin-dependent kinase 4, Retinoblastoma